Confluent and reticulated papillomatosis (Gougerot-Carteaud) successfully treated with tacalcitol.
Confluent and reticulated papillomatosis (CRP) is a rare dermatosis of unknown aetiology whose relationship to Malassezia furfur is still debated. Antifungal agents, antibiotics, retinoids, and, more recently, calcipotriol have been successfully used as treatment. The authors report on a 14-year-old female with confluent and reticulated papillomatosis in whom M. furfur was found. Anti-fungal therapy eliminated the fungus, but did not achieve the disappearance of the lesions. Further treatment with tacalcitol was successful, supporting the theory that CRP might be a disorder of keratinization. To the authors' knowledge, this is the first patient treated with tacalcitol for this entity.
Ginarte
M
M
Department of Dermatology, Complejo Hospitalario Universitario de Santiago, Faculty of Medicine, Santiago de Compostela, Spain. mginartev@meditex.es
Fabeiro
J M
JM
Toribio
J
J
D000293:Adolescent; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004100:Dihydroxycholecalciferols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010212:Papilloma / Q000188:drug therapy*; D012155:Reticulin / Q000187:drug effects*
D003879:Dermatologic Agents; D004100:Dihydroxycholecalciferols; D012155:Reticulin; C023850:1 alpha,24-dihydroxyvitamin D3